Red-flag route / read the offer carefully
Claims that deserve another question
Keep the offer in front of you. Read the claim exactly, then ask what record supports it. FDA means Food and Drug Administration.
Advertising and product checks as of September 2026.
“Approved” on a made-to-order offer versus “research” on a treatment offer
A claim of FDA approval
Compounded means made to order.
A compounded medicine has no FDA approval; claiming that it does is false under the September 2026 FDA position.
Ask whether the claim concerns the actual preparation or a different approved product.
Ask for the product record, not a badge.
A research label
FDA warns against unapproved weight-loss products promoted to people under research labels because their quality is unknown and they may be harmful.
Ask why a proposed treatment carries that label.
The Federal Trade Commission cautions that a health website’s seemingly official seal or guarantee may be a fake.
Read the records behind this ↓Can it be dispensed without a prescription?
Federal law in September 2026 calls for prescription medicines to be supplied only on a valid prescription, with a licensed practitioner as the prescriber.
A practitioner is the professional allowed to prescribe. Ask who does the assessment and how that person’s Nevada record can be checked.
Can the pharmacy on the label be checked?
FDA has found fraudulent compounded products with labels naming pharmacies that do not exist.
Get the pharmacy’s exact name. Use the Nevada board’s record and ask the board about a match you cannot find.
Does a low price settle the question?
FDA flags implausible discounts as a concern, but a low price alone cannot distinguish a legitimate cash offer from a problem.
Read the price terms beside the licence and product checks. Ask what the price includes and what it becomes later.
What about a promise of a sure result?
Nevada’s medical-board advertising rule forbids people licensed by that board from guaranteeing treatment results, as of September 2026.
Ask what supports the proposed outcome and what could lead the person treating you to change the plan. A clear explanation leaves room for those questions.
Notes for this page
These notes use the rules and care records checked in September 2026.
A · Misleading approval and equivalence claims
FDA: advertising compounded medicines ↗B · Research labels and fraudulent products
FDA: unapproved weight-loss concerns ↗C · Prescription and discount checks
FDA: checking an online pharmacy ↗D · Seals and logos are not proof
FTC: health offers on the web ↗E · The medical board’s advertising rule
Nevada Legislature: medical advertising limits ↗